[논문]Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and coronavirus disease-2019 (COVID-19): The epidemic and the challenges

Lai, Chih-Cheng; Shih, Tzu-Ping; Ko, Wen-Chien; Tang, Hung-Jen; Hsueh, Po-Ren

doi:10.1016/j.ijantimicag.2020.105924

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and coronavirus disease-2019 (COVID-19): The epidemic and the challenges 원문보기

International journal of antimicrobial agents, v.55 no.3, 2020년, pp.105924 -

Lai, Chih-Cheng (Department of Internal Medicine, Kaohsiung Veterans General Hospital) , Shih, Tzu-Ping (Department of Family Medicine, Kaohsiung Veterans General Hospital) , Ko, Wen-Chien (Department of Medicine, College of Medicine, National Cheng Kung University) , Tang, Hung-Jen (Department of Medicine, Chi Mei Medical Center) , Hsueh, Po-Ren (Department of Laboratory Medicine, National Taiwan University Hospital, National Taiwan University College of Medicine)

Abstract ▼ AI-Helper

ABSTRACT The emergence of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2; previously provisionally named 2019 novel coronavirus or 2019-nCoV) disease (COVID-19) in China at the end of 2019 has caused a large global outbreak and is a major public health issue. As of 11 February 2020, data from the World Health Organization (WHO) have shown that more than 43 000 confirmed cases have been identified in 28 countries/regions, with >99% of cases being detected in China. On 30 January 2020, the WHO declared COVID-19 as the sixth public health emergency of international concern. SARS-CoV-2 is closely related to two bat-derived severe acute respiratory syndrome-like coronaviruses, bat-SL-CoVZC45 and bat-SL-CoVZXC21. It is spread by human-to-human transmission via droplets or direct contact, and infection has been estimated to have mean incubation period of 6.4 days and a basic reproduction number of 2.24–3.58. Among patients with pneumonia caused by SARS-CoV-2 (novel coronavirus pneumonia or Wuhan pneumonia), fever was the most common symptom, followed by cough. Bilateral lung involvement with ground-glass opacity was the most common finding from computed tomography images of the chest. The one case of SARS-CoV-2 pneumonia in the USA is responding well to remdesivir, which is now undergoing a clinical trial in China. Currently, controlling infection to prevent the spread of SARS-CoV-2 is the primary intervention being used. However, public health authorities should keep monitoring the situation closely, as the more we can learn about this novel virus and its associated outbreak, the better we can respond. Highlights Emergence of 2019 novel coronavirus (2019-nCoV) in China has caused a large global outbreak and major public health issue. At 9 February 2020, data from the WHO has shown >37 000 confirmed cases in 28 countries (>99% of cases detected in China). 2019-nCoV is spread by human-to-human transmission via droplets or direct contact. Infection estimated to have an incubation period of 2–14 days and a basic reproduction number of 2.24–3.58. Controlling infection to prevent spread of the 2019-nCoV is the primary intervention being used.

주제어

참고문헌 (48)

1 Lu H. Stratton C.W. Tang Y.W. Outbreak of pneumonia of unknown etiology in Wuhan China: the mystery and the miracle J Med Virol 2020 Jan 16 10.1002/jmv.25678 [Epub ahead of print]

상세보기
2 Li Q. Guan X. Wu P. Wang X. Zhou L. Tong Y. Early transmission dynamics in Wuhan, China, of novel coronavirus-infected pneumonia N Engl J Med 2020 Jan 29 10.1056/NEJMoa2001316 [Epub ahead of print]

상세보기
3 Gorbalenya A.E. Baker S.C. Baric R.S. de Groot R.J. Drosten C. Gulyaeva A.A. Severe acute respiratory syndrome-related coronavirus: the species and its viruses―a statement of the Coronavirus Study Group bioRxiv 2020 Feb 11 10.1101/2020.02.07.937862
4 Chen N. Zhou M. Dong X. Qu J. Gong F. Han Y. Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study Lancet 395 2020 507 513 10.1016/S0140-6736(20)30211-7 32007143

상세보기
5 Huang C. Wang Y. Li X. Ren L. Zhao J. Hu Y. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China Lancet 395 2020 497 506 10.1016/S0140-6736(20)30183-5 31986264

상세보기
6 Wang C. Horby P.W. Hayden F.G. Gao G.F. A novel coronavirus outbreak of global health concern Lancet 395 2020 470 473 10.1016/S0140-6736(20)30185-9 31986257

상세보기
7 Holshue M.L. DeBolt C. Lindquist S. Lofy K.H. Wiesman J. Bruce H. First case of 2019 novel coronavirus in the United States N Engl J Med 2020 Jan 31 10.1056/NEJMoa2001191 [Epub ahead of print]

상세보기
8 Wang D. Hu B. Hu C. Zhu F. Liu X. Zhang J. Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China JAMA 2020 Feb 7 10.1001/jama.2020.1585 [Epub ahead of print]

상세보기
9 Chang D. Lin M. Wei L. Xie L. Zhu G. Dela Cruz C.S. Epidemiologic and clinical characteristics of novel coronavirus infections involving 13 patients outside Wuhan, China JAMA 2020 Feb 7 10.1001/jama.2020.1623 [Epub ahead of print]

상세보기
10 Carlos W.G. Dela Cruz C.S. Cao B. Pasnick S. Jamil S. Novel Wuhan (2019-nCoV) coronavirus Am J Respir Crit Care Med 201 2020 P7 P8 10.1164/rccm.2014P7 32004066

상세보기
11 Zhao S. Lin Q. Ran J. Musa S.S. Yang G. Wang W. Preliminary estimation of the basic reproduction number of novel coronavirus (2019-nCoV) in China, from 2019 to 2020: a data-driven analysis in the early phase of the outbreak Int J Infect Dis 92 2020 214 217 10.1016/j.ijid.2020.01.050 32007643

상세보기
12 Biscayart C. Angeleri P. Lloveras S. Chaves T. Schlagenhauf P. Rodriguez-Morales A.J. The next big threat to global health? 2019 novel coronavirus (2019-nCoV): What advice can we give to travellers? ― Interim recommendations January 2020, from the Latin-American Society for Travel Medicine (SLAMVI) Travel Med Infect Dis 2020 101567 10.1016/j.tmaid.2020.101567

상세보기
13 Munster V.J. Koopmans M. van Doremalen N. van Riel D. de Wit E. A novel coronavirus emerging in China―key questions for impact assessment N Engl J Med 2020 Jan 24 10.1056/NEJMp2000929 [Epub ahead of print]

상세보기
14 Yoo J.H. The fight against the 2019-nCoV outbreak: an arduous march has just begun J Korean Med Sci 35 2020 e56 10.3346/jkms.2020.35.e56 31997618

상세보기
15 Lee K.H. Yoo S.G. Cho Y. Kwon D.E. La Y. Han S.H. Characteristics of community-acquired respiratory viruses infections except seasonal influenza in transplant recipients and non-transplant critically ill patients J Microbiol Immunol Infect 2019 Jun 19 10.1016/j.jmii.2019.05.007 [Epub ahead of print]

상세보기
16 Chou C.C. Shen C.F. Chen S.J. Chen H.M. Wang Y.C. Chang W.S. Recommendations and guidelines for the treatment of pneumonia in Taiwan J Microbiol Immunol Infect 52 2019 172 199 10.1016/j.jmii.2018.11.004 30612923

상세보기
17 Lee J.Y. Yang P.C. Chang C. Lin I.T. Ko W.C. Cia C.T. Community-acquired adenoviral and pneumococcal pneumonia complicated by pulmonary aspergillosis in an immunocompetent adult J Microbiol Immunol Infect 52 2019 838 839 10.1016/j.jmii.2019.05.014 31337539

상세보기
18 Su I.C. Lee K.L. Liu H.Y. Chuang H.C. Chen L.Y. Lee Y.J. Severe community-acquired pneumonia due to Pseudomonas aeruginosa coinfection in an influenza A(H1N1)pdm09 patient J Microbiol Immunol Infect 52 2019 365 366 10.1016/j.jmii.2018.05.007 29958866

상세보기
19 Lee S.H. Ruan S.Y. Pan S.C. Lee T.F. Chien J.Y. Hsueh P.R. Performance of a multiplex PCR pneumonia panel for the identification of respiratory pathogens and the main determinants of resistance from the lower respiratory tract specimens of adult patients in intensive care units J Microbiol Immunol Infect 52 2019 920 928 10.1016/j.jmii.2019.10.009 31806539

상세보기
20 Hung H.M. Yang S.L. Chen C.J. Chiu C.H. Kuo C.Y. Huang K.A. Molecular epidemiology and clinical features of rhinovirus infections among hospitalized patients in a medical center in Taiwan J Microbiol Immunol Infect 52 2019 233 241 10.1016/j.jmii.2018.08.009 30201131

상세보기
21 Lin G.L. Lu C.Y. Chen J.M. Lee P.I. Ho S.Y. Weng K.C. Molecular epidemiology and clinical features of adenovirus infection in Taiwanese children, 2014 J Microbiol Immunol Infect 52 2019 215 224 10.1016/j.jmii.2018.07.005 30172758

상세보기
22 Chan J.F. Kok K.H. Zhu Z. Chu H. To K.K. Yuan S. Genomic characterization of the 2019 novel human-pathogenic coronavirus isolated from a patient with atypical pneumonia after visiting Wuhan Emerg Microbes Infect 9 2020 221 236 10.1080/22221751.2020.1719902 31987001

상세보기
23 Lu R. Zhao X. Li J. Niu P. Yang B. Wu H. Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding Lancet 2020 Jan 30 10.1016/S0140-6736(20)30251-8 [Epub ahead of print]

상세보기
24 Zhu N. Zhang D. Wang W. Li X. Yang B. Song J. A novel coronavirus from patients with pneumonia in China, 2019 N Engl J Med 2020 Jan 24 10.1056/NEJMoa2001017 [Epub ahead of print]

상세보기
25 Jiang S. Du L. Shi Z. An emerging coronavirus causing pneumonia outbreak in Wuhan, China: calling for developing therapeutic and prophylactic strategies Emerg Microbes Infect 9 2020 275 277 10.1080/22221751.2020.1723441 32005086

상세보기
26 Ren L.L. Wang Y.M. Wu Z.Q. Xiang Z.C. Guo L. Xu T. Identification of a novel coronavirus causing severe pneumonia in human: a descriptive study Chin Med J (Engl) 2020 Jan 30 10.1097/CM9.0000000000000722 [Epub ahead of print]

상세보기
27 Chen L. Liu W. Zhang Q. Xu K. Ye G. Wu W. RNA based mNGS approach identifies a novel human coronavirus from two individual pneumonia cases in 2019 Wuhan outbreak Emerg Microbes Infect 9 2020 313 319 10.1080/22221751.2020.1725399 32020836

상세보기
28 Zhou P. Yang X.L. Wang X.G. Hu B. Zhang L. Zhang W. A pneumonia outbreak associated with a new coronavirus of probable bat origin Nature 2020 Feb 3 10.1038/s41586-020-2012-7 [Epub ahead of print]

상세보기
29 Wu J.T. Leung K. Leung G.M. Nowcasting and forecasting the potential domestic and international spread of the 2019-nCoV outbreak originating in Wuhan, China: a modelling study Lancet 2020 Jan 31 10.1016/S0140-6736(20)30260-9 [Epub ahead of print]

상세보기
30 Backer J.A. Klinkenberg D. Wallinga J. Incubation period of 2019 novel coronavirus (2019-nCoV) infections among travelers from Wuhan, China, 20？28 January 2020 Euro Surveill 25 2020 10.2807/1560-7917.ES.2020.25.5.2000062

상세보기
31 Chen Z.M. Fu J.F. Shu Q. Chen Y.H. Hua C.Z. Li F.B. Diagnosis and treatment recommendations for pediatric respiratory infection caused by the 2019 novel coronavirus World J Pediatr 2020 Feb 5 10.1007/s12519-020-00345-5 [Epub ahead of print]

상세보기
32 Ryu S. Chun B.C. Epidemiological characteristics of 2019 novel coronavirus: an interim review Epidemiol Health 42 2020 e2020006 10.4178/epih.e2020006

상세보기
33 Chung M. Bernheim A. Mei X. Zhang N. Huang M. Zeng X. CT imaging features of 2019 novel coronavirus (2019-nCoV) Radiology 2020 Feb 4 10.1148/radiol.2020200230 [Epub ahead of print]

상세보기
34 Kanne J.P. Chest CT findings in 2019 novel coronavirus (2019-nCoV) infections from Wuhan, China: key points for the radiologist Radiology 2020 Feb 4 10.1148/radiol.2020200241 [Epub ahead of print]

상세보기
35 Song F. Shi N. Shan F. Zhang Z. Shen J. Lu H. Emerging coronavirus 2019-nCoV pneumonia Radiology 2020 Feb 6 10.1148/radiol.2020200274 [Epub ahead of print]

상세보기
36 Lu H. Drug treatment options for the 2019-new coronavirus (2019-nCoV) Biosci Trends 2020 Jan 28 10.5582/bst.2020.01020 [Epub ahead of print]

상세보기
37 Wang M. Cao R. Zhang L. Yang X. Liu J. Xu M. Remdesivir and chloroquine effectively inhibit the recently emerged novel coronavirus (2019-nCoV) in vitro Cell Res 2020 Feb 4 10.1038/s41422-020-0282-0 [Epub ahead of print]

상세보기
38 Liu W. Morse J.S. Lalonde T. Xu S. Learning from the past: possible urgent prevention and treatment options for severe acute respiratory infections caused by 2019-nCoV Chembiochem 2020 Feb 5 10.1002/cbic.202000047 [Epub ahead of print]

상세보기
39 Rolain J.M. Colson P. Raoult D. Recycling of chloroquine and its hydroxyl analogue to face bacterial, fungal and viral infections in the 21st century Int J Antimicrob Agents 30 2007 297 308 10.1016/j.ijantimicag.2007.05.015 17629679

상세보기
40 Wang W. Tang J. Wei F. Updated understanding of the outbreak of 2019 novel coronavirus (2019-nCoV) in Wuhan, China J Med Virol 2020 Jan 29 10.1002/jmv.25689 [Epub ahead of print]

상세보기
41 Kim J.Y. Choe P.G. Oh Y. Oh K.J. Kim J. Park S.J. The first case of 2019 novel coronavirus pneumonia imported into Korea from Wuhan, China: implication for infection prevention and control measures J Korean Med Sci 35 2020 e61 10.3346/jkms.2020.35.e61 32030925

상세보기
42 World Health Organization (WHO). Novel coronavirus (2019-nCoV). Situation report . https://www.who.int/docs/default-source/coronaviruse/situation-reports/20200207-sitrep-18-ncov.pdf?sfvrsn=fa644293_2 [accessed 9 February 2020].
43 Patel A. Jernigan D.B. 2019-nCoV CDC Response Team Initial public health response and interim clinical guidance for the 2019 novel coronavirus outbreak―United States, December 31, 2019？February 4, 2020 MMWR Morb Mortal Wkly Rep 69 2020 140 146 10.15585/mmwr.mm6905e1 32027631

상세보기
44 Casanova L.M. Jeon S. Rutala W.A. Weber D.J. Sobsey M.D. Effects of air temperature and relative humidity on coronavirus survival on surfaces Appl Environ Microbiol 76 2010 2712 2717 10.1128/AEM.02291-09 20228108

상세보기
45 Kampf G. Todt D. Pfaeder S. Steinmann E. Persistence of coronaviruses on inanimate surfaces and its inactivation with biocidal agents J Hosp Infect 2020 Feb 6 10.1016/j.jhin.2020.01.022 [Epub ahead of print]

상세보기
46 Guan W.J. Ni Z.Y. Hu Y. Laing W.H. Ou C.Q. He J.X. Clinical characteristics of 2019 novel coronavirus infection in China medRxiv 2020 Feb 9 10.1101/2020.02.06.20020974
47 Li G. Fan Y. Lai Y. Han T. Li Z. Zhou P. Coronavirus infections and immune responses J Med Virol 2020 Jan 25 10.1002/jmv.25685 [Epub ahead of print]

상세보기
48 Russell C.D. Millar J.E. Baillie J.K. Clinical evidence does not support corticosteroid treatment for 2019-nCoV lung injury Lancet 395 2020 473 475 10.1016/S0140-6736(20)30317-2 32043983

상세보기

표제어: PCR

동의어: Packet Collision Rate

용어 설명 출처 목록 (6)

용어 설명: PCR은 세균 특이성이 있는 primer를 이용하여 적은 수의 세균이 있을지라도 쉽게 검출할 수 있는 유용한 방법이며, 이를 이용하여 구강 내 치면세균막이나 타액에서 직접 세균을 검출할 수 있게 되었다[8].

내보내기 구분	파일저장 인쇄 메일전송
구성항목	기본정보 상세정보 관리번호, 논문명, 저널/프로시딩명, 저자 , 발행년, 권, 호, 시작페이지, 끝페이지, 발행기관 관리번호, 논문명, 대등논문명, 저자 , 저널/프로시딩명, 발행기관, 발행년, 발행언어, 권, 호, 시작페이지, 끝페이지, ISBN, ISSN, 주제분야, 키워드, 초록(한글), 초록(영문), 저자(소속기관)
저장형식	Text(ASCII format) Excel format RefWorks Direct Export RIS format (for Reference Manager, ProCite, EndNote), Scholar's Aids, Mendeley
메일정보	받는사람 (필수) @ 보내는사람 (선택) @ 제목 내용 KISTI 검색결과 이메일 서비스
안내	총 건의 자료가 검색되었습니다. 다운받으실 자료의 인덱스를 입력하세요. (1-10,000) 검색결과의 순서대로 최대 10,000건 까지 다운로드가 가능합니다. 데이타가 많을 경우 속도가 느려질 수 있습니다.(최대 2~3분 소요) 다운로드 파일은 UTF-8 형태로 저장됩니다. 파일의 내용이 제대로 보이지 않을실 때는 웹브라우저 상단의 보기 -> 인코딩 -> 자동선택 여부를 확인하십시오. ~ Text(ASCII format) Excel format

연합인증

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and coronavirus disease-2019 (COVID-19): The epidemic and the challenges 원문보기

Abstract ▼ AI-Helper

주제어

참고문헌 (48)

이 논문을 인용한 문헌

관련 콘텐츠

원문 보기

원문 URL 링크

오픈액세스(OA) 유형

이 논문과 함께 이용한 콘텐츠

AI-Helper ※ AI-Helper는 오픈소스 모델을 사용합니다.

선택된 텍스트